572 related items for PubMed ID: 9367464
1. Evaluation of corticotropin releasing factor stimulation and basal markers of hypothalamic-pituitary-adrenal axis suppression in asthmatic patients.
Clark DJ, Lipworth BJ.
Chest; 1997 Nov 05; 112(5):1248-52. PubMed ID: 9367464
[Abstract] [Full Text] [Related]
2. Effects of budesonide by means of the Turbuhaler on the hypothalmic-pituitary-adrenal axis in asthmatic subjects: a dose-response study.
Aaronson D, Kaiser H, Dockhorn R, Findlay S, Korenblat P, Thorsson L, Källén A.
J Allergy Clin Immunol; 1998 Mar 05; 101(3):312-9. PubMed ID: 9525445
[Abstract] [Full Text] [Related]
3. Comparative adrenal suppression with inhaled budesonide and fluticasone propionate in adult asthmatic patients.
Clark DJ, Grove A, Cargill RI, Lipworth BJ.
Thorax; 1996 Mar 05; 51(3):262-6. PubMed ID: 8779128
[Abstract] [Full Text] [Related]
4. Effects of high-dose inhaled fluticasone propionate on the hypothalamic-pituitary-adrenal axis in asthmatic patients with severely impaired lung function.
Lee DK, Bates CE, Currie GP, Cowan LM, McFarlane LC, Lipworth BJ.
Ann Allergy Asthma Immunol; 2004 Sep 05; 93(3):253-8. PubMed ID: 15478385
[Abstract] [Full Text] [Related]
5. Adrenocortical activity with repeated administration of one-daily inhaled fluticasone propionate and budesonide in asthmatic adults.
Wilson AM, Clark DJ, Devlin MM, McFarlane LC, Lipworth BJ.
Eur J Clin Pharmacol; 1998 Jan 05; 53(5):317-20. PubMed ID: 9516029
[Abstract] [Full Text] [Related]
6. Systemic bioactivity profiles of oral prednisolone and nebulized budesonide in adult asthmatics.
Wilson AM, McFarlane LC, Lipworth BJ.
Chest; 1998 Oct 05; 114(4):1022-7. PubMed ID: 9792571
[Abstract] [Full Text] [Related]
7. Adrenocortical activity with repeated twice daily dosing of fluticasone propionate and budesonide given via a large volume spacer to asthmatic school children.
Lipworth BJ, Clark DJ, McFarlane LC.
Thorax; 1997 Aug 05; 52(8):686-9. PubMed ID: 9337826
[Abstract] [Full Text] [Related]
8. Evaluation of hypothalamic-pituitary-adrenal axis suppression by low-dose (0.5 microg) and standard-dose (250 microg) adrenocorticotropic hormone (ACTH) tests in asthmatic children treated with inhaled corticosteroid.
Ozbek OY, Turktas I, Bakirtas A, Bideci A.
J Pediatr Endocrinol Metab; 2006 Aug 05; 19(8):1015-23. PubMed ID: 16995587
[Abstract] [Full Text] [Related]
9. Evaluation of hypothalamic-pituitary-adrenal axis (HPA) suppression by low-dose (0.5 microg) and standard-dose (250 microg) adrenocorticotropic hormone (ACTH) tests in asthmatic children treated with inhaled corticosteroid (JPEM 2006; 19: 1015-1023).
Priftis KN, Papadimitriou A, Anthracopoulos MB, Fretzayas A, Nicolaidou P.
J Pediatr Endocrinol Metab; 2007 Feb 05; 20(2):261; author reply 261-2. PubMed ID: 17396445
[No Abstract] [Full Text] [Related]
10. Long-term effect of budesonide on hypothalamic-pituitary-adrenal axis function in children with mild to moderate asthma.
Bacharier LB, Raissy HH, Wilson L, McWilliams B, Strunk RC, Kelly HW.
Pediatrics; 2004 Jun 05; 113(6):1693-9. PubMed ID: 15173493
[Abstract] [Full Text] [Related]
11. Systemic activity of inhaled corticosteroid treatment in asthmatic children: corticotrophin releasing hormone test.
Pescollderungg L, Radetti G, Gottardi E, Peroni DG, Pietrobelli A, Boner AL.
Thorax; 2003 Mar 05; 58(3):227-30. PubMed ID: 12612299
[Abstract] [Full Text] [Related]
12. Comparable effects of inhaled fluticasone propionate and budesonide on the HPA-axis in adult asthmatic patients.
Ringdal N, Lundbäck B, Alton M, Rak S, Eivindson A, Bratten G, Kjaersgaard P.
Respir Med; 2000 May 05; 94(5):482-9. PubMed ID: 10868712
[Abstract] [Full Text] [Related]
13. Effects of budesonide inhalation suspension on hypothalamic-pituitary-adrenal-axis function in infants and young children with persistent asthma.
Irani AM, Cruz-Rivera M, Fitzpatrick S, Hoag J, Smith JA.
Ann Allergy Asthma Immunol; 2002 Mar 05; 88(3):306-12. PubMed ID: 11926625
[Abstract] [Full Text] [Related]
14. Hypothalamic-pituitary-adrenal axis suppression in asthmatic school children.
Zöllner EW, Lombard CJ, Galal U, Hough FS, Irusen EM, Weinberg E.
Pediatrics; 2012 Dec 05; 130(6):e1512-9. PubMed ID: 23147980
[Abstract] [Full Text] [Related]
15. Effects of repeated once daily dosing of three intranasal corticosteroids on basal and dynamic measures of hypothalamic-pituitary-adrenal-axis activity.
Wilson AM, McFarlane LC, Lipworth BJ.
J Allergy Clin Immunol; 1998 Apr 05; 101(4 Pt 1):470-4. PubMed ID: 9564799
[Abstract] [Full Text] [Related]
16. Desmopressin and low-dose ACTH test in rheumatoid arthritis.
Foppiani L, Cutolo M, Sessarego P, Sulli A, Prete C, Seriolo B, Giusti M.
Eur J Endocrinol; 1998 Mar 05; 138(3):294-301. PubMed ID: 9539304
[Abstract] [Full Text] [Related]
17. Adrenal suppression with chronic dosing of fluticasone propionate compared with budesonide in adult asthmatic patients.
Clark DJ, Lipworth BJ.
Thorax; 1997 Jan 05; 52(1):55-8. PubMed ID: 9039246
[Abstract] [Full Text] [Related]
18. The hypothalamic-pituitary-adrenal axis of patients with severe sepsis: altered response to corticotropin-releasing hormone.
Schroeder S, Wichers M, Klingmüller D, Höfer M, Lehmann LE, von Spiegel T, Hering R, Putensen C, Hoeft A, Stüber F.
Crit Care Med; 2001 Feb 05; 29(2):310-6. PubMed ID: 11246311
[Abstract] [Full Text] [Related]
19. Administration of RU 486 for 8 days in normal volunteers: antiglucocorticoid effect with no evidence of peripheral cortisol deprivation.
Bertagna X, Escourolle H, Pinquier JL, Coste J, Raux-Demay MC, Perles P, Silvestre L, Luton JP, Strauch G.
J Clin Endocrinol Metab; 1994 Feb 05; 78(2):375-80. PubMed ID: 8106625
[Abstract] [Full Text] [Related]
20. A comparison of methods for assessing hypothalamic-pituitary-adrenal (HPA) axis activity in asthma patients treated with inhaled corticosteroids.
Nelson HS, Stricker W, Casale TB, Raff H, Fourré JA, Aron DC, Newman KB.
J Clin Pharmacol; 2002 Mar 05; 42(3):319-26. PubMed ID: 11865969
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
